NCT04870944 2026-02-24CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and LymphomaChildren's Oncology GroupPhase 1/2 Recruiting63 enrolled
NCT05956821 2025-12-08Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of AgeUniversity of MiamiPhase 1/2 Recruiting20 enrolled
NCT05278208 2025-10-20Lutathera for Treatment of Recurrent or Progressive High-Grade CNS TumorsNationwide Children's HospitalPhase 1/2 Recruiting65 enrolled